ATH 12.5% 0.5¢ alterity therapeutics limited

Much as I hate to side with skint on most issues, gavel, in this...

  1. 116 Posts.
    Much as I hate to side with skint on most issues, gavel, in this case I'll make an exception.
    Your comment asserting that the"root cause is known to be genetic predisposition" reveals not only your profound ignorance of AD, the biggest risk factor for which is advancing age, but also of modern medicine in general via an equally incorrect implication that there are no effective therapies for disease that ARE genetically predetermined (type 2 diabetes, haemochromatosis, cystic fibrosis, etc,etc).
    Although I've declared my scepticism before in this forum about the prospects of a cure, I do believe that disease modifying drugs hold promise as preventive agents.
    Have bought back in at these prices in anticipation of the current placement presaging the announcement of the definitive pase 2 trial that has been long awaited.
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.5¢
Change
0.001(12.5%)
Mkt cap ! $23.94M
Open High Low Value Volume
0.4¢ 0.5¢ 0.4¢ $508 124.6K

Buyers (Bids)

No. Vol. Price($)
103 97947018 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 31179262 15
View Market Depth
Last trade - 11.42am 25/07/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.